OzUK and Ab Initio support early stage clinical trials

Learn how OzUK and Ab Initio can support your first in human and early stage MDI trials with conventional and lowGWP propellants.

Previous
Previous

Learn how OzUK and Ab Initio Pharma can support your MDI development program using advanced characterisation tools

Next
Next

Emerging Trends in Inhaled Drug Delivery